MYC and cholangiocarcinoma: Compared with those in normal tissues, glutamine levels are decreased in CCA tissues, and c-Myc expression is reduced in glutamine-deficient cell lines; in contrast, the combination of cisplatin (CIS) and hypoxia leads to sustained c-Myc protein expression in cells.